Filter
718
Text search:
drug
prices
Featured
74
232
Language
Document type
401
164
72
34
22
8
7
5
3
1
1
Countries
36
30
24
22
19
16
15
14
14
13
13
11
11
11
10
10
10
8
8
8
8
8
8
8
7
7
6
6
5
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
304
72
43
18
18
17
4
Toolboxes
79
56
46
44
30
24
19
17
17
11
11
9
8
8
8
7
6
4
3
3
3
2
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Accessed: 28.03.2019
World Drug Report 2017
-1-
Accessed: 14.03.2019
Perspectives on Drugs
Accessed: 22.03.2019
A summary of the national drug situation
A summary of the national drug situation
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
